These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 11230792

  • 1. Interaction of estrogen replacement therapy with the thrombophilic 20210 G/A prothrombin gene mutation for atherothrombotic vascular disease: a cross-sectional study of 275 hyperlipidemic women.
    Glueck CJ, Wang P, Fontaine RN, Sieve-Smith L, Lang JE.
    Metabolism; 2001 Mar; 50(3):360-5. PubMed ID: 11230792
    [Abstract] [Full Text] [Related]

  • 2. Estrogen replacement therapy, thrombophilia, and atherothrombosis.
    Glueck CJ, Wang P, Fontaine RN, Sieve-Smith L, Lang JE.
    Metabolism; 2002 Jun; 51(6):724-32. PubMed ID: 12037725
    [Abstract] [Full Text] [Related]

  • 3. Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the factor V Leiden mutation (resistance to activated protein C).
    Glueck CJ, Wang P, Fontaine RN, Tracy T, Sieve-Smith L, Lang JE.
    Am J Cardiol; 1999 Sep 01; 84(5):549-54. PubMed ID: 10482153
    [Abstract] [Full Text] [Related]

  • 4. Interaction of heritable and estrogen-induced thrombophilia: possible etiologies for ischemic optic neuropathy and ischemic stroke.
    Glueck CJ, Fontaine RN, Wang P.
    Thromb Haemost; 2001 Feb 01; 85(2):256-9. PubMed ID: 11246543
    [Abstract] [Full Text] [Related]

  • 5. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
    Straczek C, Oger E, Yon de Jonage-Canonico MB, Plu-Bureau G, Conard J, Meyer G, Alhenc-Gelas M, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY, Estrogen and Thromboembolism Risk (ESTHER) Study Group.
    Circulation; 2005 Nov 29; 112(22):3495-500. PubMed ID: 16301339
    [Abstract] [Full Text] [Related]

  • 6. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.
    Tirado I, Mateo J, Soria JM, Oliver A, Borrell M, Coll I, Vallvé C, Souto JC, Martínez-Sánchez E, Fontcuberta J.
    Haematologica; 2001 Nov 29; 86(11):1200-8. PubMed ID: 11694407
    [Abstract] [Full Text] [Related]

  • 7. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I, De Stefano V, Taioli E, Paciaroni K, Rossi E, Mannucci PM.
    Thromb Haemost; 2002 May 29; 87(5):791-5. PubMed ID: 12038778
    [Abstract] [Full Text] [Related]

  • 8. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.
    Bank I, Libourel EJ, Middeldorp S, Van Pampus EC, Koopman MM, Hamulyák K, Prins MH, Van Der Meer J, Büller HR.
    Arch Intern Med; 2004 Sep 27; 164(17):1932-7. PubMed ID: 15451770
    [Abstract] [Full Text] [Related]

  • 9. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N, Koren S, Greer WL, Fortin PR, Rauch J, Fortin I, Senécal JL, Docherty P, Hanly JG.
    J Rheumatol; 2002 Aug 27; 29(8):1683-8. PubMed ID: 12180730
    [Abstract] [Full Text] [Related]

  • 10. Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events.
    Ricart JM, Vayá A, Todolí J, Calvo J, Villa P, Estellés A, España F, Santaolaria M, Corella D, Aznar J.
    Thromb Haemost; 2006 Apr 27; 95(4):618-24. PubMed ID: 16601831
    [Abstract] [Full Text] [Related]

  • 11. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I, Legnani C, Bucciarelli P, Grandone E, De Stefano V, Mannucci PM.
    Thromb Haemost; 2001 Sep 27; 86(3):800-3. PubMed ID: 11583310
    [Abstract] [Full Text] [Related]

  • 12. Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma.
    Pihusch R, Danzl G, Scholz M, Harich D, Pihusch M, Lohse P, Hiller E.
    Cancer; 2002 Jun 15; 94(12):3120-6. PubMed ID: 12115343
    [Abstract] [Full Text] [Related]

  • 13. [Genetic thrombophilic defects (Factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss].
    Kovacheva K, Ivanov P, Konova E, Simeonova M, Komsa-Penkova R.
    Akush Ginekol (Sofiia); 2007 Jun 15; 46(7):10-6. PubMed ID: 18333414
    [Abstract] [Full Text] [Related]

  • 14. Homozygotes for prothrombin gene 20210 A allele in a thrombophilic family without clinical manifestations of venous thromboembolism.
    Souto JC, Mateo J, Soria JM, Llobet D, Coll I, Borrell M, Fontcuberta J.
    Haematologica; 1999 Jul 15; 84(7):627-32. PubMed ID: 10406905
    [Abstract] [Full Text] [Related]

  • 15. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J.
    Haematologica; 2008 May 15; 93(5):729-34. PubMed ID: 18387978
    [Abstract] [Full Text] [Related]

  • 16. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F, Duchemin J, Leroyer C, Delahousse B, Abgrall JF, Mottier D, Groupe d'Etude de la Thrombose de Bretagne Occidentale (G.E.T.B.O).
    Thromb Haemost; 2008 Jan 15; 99(1):223-8. PubMed ID: 18217158
    [Abstract] [Full Text] [Related]

  • 17. Thrombophilia-hypofibrinolysis and atherothrombotic cardiovascular disease < or = age 45 years.
    Glueck CJ, Munjal J, Aregawi D, Agloria M, Winiarska M, Khalil Q, Wang P.
    Transl Res; 2007 Aug 15; 150(2):93-100. PubMed ID: 17656328
    [Abstract] [Full Text] [Related]

  • 18. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B, Schindewolf M, Zgouras D, Erbe M, Jarosch-Preusche M, Lindhoff-Last E.
    Thromb Res; 2008 Aug 15; 121(6):743-50. PubMed ID: 17804043
    [Abstract] [Full Text] [Related]

  • 19. Thrombophilic risk factors and peripheral arterial disease severity.
    Sartori M, Favaretto E, Legnani C, Cini M, Conti E, Amato A, Palareti G.
    Thromb Haemost; 2010 Jul 15; 104(1):71-7. PubMed ID: 20390230
    [Abstract] [Full Text] [Related]

  • 20. Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia.
    Heylen E, Miljic P, Willemse J, Djordjevic V, Radojkovic D, Colovic M, Elezovic I, Hendriks D.
    Thromb Res; 2009 Sep 15; 124(4):427-32. PubMed ID: 19195685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.